Expansion of the Healthcare Big Data Business through the Addition of 株式会社ケーシップ
First written in FY2025-H1. 4 of 5 entries say "Advanced", first in FY2025. Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「This was due in part to improved profitability at K-Ship, which joined the business from the previous fiscal year.」
Following ケーシップ's addition to the business, improved profitability was confirmed as a factor behind the full-year increase in profit in the healthcare big data business. - 2026-05-14AdvancedRevision of earnings forecasts
「This was due in part to improved profitability at K-Ship, which joined the business from the previous fiscal year.」
Improved profitability at K-Ship was confirmed as a factor behind the full-year earnings growth of the Medical Big Data Business. - FY2026-H1AdvancedAnnual report
「The main factors were revenue growth in the claims review service, data utilization service, and cloud-based claims management service for public assistance, among others, as well as improved profitability at 株式会社ケーシップ, which joined this business in the previous fiscal year.」
For ケーシップ, which joined the healthcare big data business in the previous fiscal year, improved profitability was explicitly identified as a factor contributing to improved performance. - FY2025AdvancedAnnual report
「In the healthcare big data business, efforts focused on improving automated claims inspection performance and expanding services resulted in research and development expenses of ¥128.611 million.」
In the healthcare big data business following the addition of ケーシップ, revenue increased from claims inspection and analysis services and other operations, bringing full-year revenue to ¥3.150 billion. The expansion of the business platform and the results of research and development and service expansion were confirmed. - FY2025-H1First statedAnnual report
「Profit declined due to higher personnel expenses and strategic investments aimed at medium- to long-term growth, including the addition of 株式会社ケーシップ to the business from the current consolidated fiscal year.」
A business combination with 株式会社ケーシップ was completed on 26 January 2024, and the company was shown to have joined the healthcare big data business during the current interim consolidated accounting period. Strategic investments, including in the company, were made as part of the expansion of the business platform with a view to medium- to long-term growth.